Victor J Navarro
Affiliation: Thomas Jefferson University
- Identification of patients with hepatitis C virus infection in New Haven County primary care practicesVictor J Navarro
Jefferson Medical College, Philadelphia, Pennsylvania, USA
J Clin Gastroenterol 36:431-5. 2003..The objectives of this study were to describe HCV practices of New Haven County PCPs...
- Over-the-counter analgesics in cirrhotic patients: a case-control study examining the risk of hospitalization for liver-associated eventsJonathan M Fenkel
Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA
Scand J Gastroenterol 45:1101-9. 2010..To assess the association between over-the-counter analgesic (OTCA) use and hospitalization for liver-associated events in cirrhotic patients...
- Prevalence of HCV risk factors in Hispanic-American sub populationsStacey B Trooskin
Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA 19107, USA
J Immigr Minor Health 12:915-20. 2010..Furthermore, the prevalence of risk factors increase among Hispanic immigrants after living in the US. These findings have a direct public health impact by providing rationale to focus HCV prevention efforts on recent immigrants...
- Catechins in dietary supplements and hepatotoxicityVictor J Navarro
Division of Hepatology, Einstein Medical Center, 5401 Old York Road, Suite 505, Philadelphia, PA 19141, USA
Dig Dis Sci 58:2682-90. 2013..Many herbal dietary supplements (HDS) contain green tea extract (GTE) and its component catechins, although their presence may not always be indicated on the product label...
- Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitisVaibhav Mehendiratta
Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
Clin Gastroenterol Hepatol 7:98-103. 2009....
- Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observationsDongil Choi
Department of Radiology, Thomas Jefferson University Hospital, 132 S 10th St, 1094 Main Bldg, Philadelphia, PA 19107, USA
Radiology 244:776-83. 2007..To retrospectively evaluate the effect of indeterminate or false-negative findings at magnetic resonance (MR) imaging on eligibility for curative treatment of hepatocellular carcinoma (HCC)...
- Human drug hepatotoxicity: a contemporary clinical perspectiveDavid N Assis
Thomas Jefferson University Hospital, Department of Medicine, Suite 805 College, 1025 Walnut Street, Philadelphia, PA 19107, USA
Expert Opin Drug Metab Toxicol 5:463-73. 2009..The rising number of marketed drugs, aging population and polypharmacy make it imperative to understand the clinical presentation of DILI and the processes used in the assessment of causality and early detection...
- Safety of peginterferon in the treatment of chronic hepatitis CNikroo Hashemi
Thomas Jefferson University, Division of Gastroenterology and Hepatology, Philadelphia, PA, USA
Expert Opin Drug Saf 7:771-81. 2008..Anticipation, recognition and proper management of these side effects are important to ensure compliance with therapy and achievement of sustained virologic response...
- Limited sampling estimates of epigallocatechin gallate exposures in cirrhotic and noncirrhotic patients with hepatitis C after single oral doses of green tea extractDina Halegoua-De Marzio
Division of Gastroenterology and Hepatology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
Clin Ther 34:2279-2285.e1. 2012..However, cirrhosis might affect EGCG disposition and augment its reported dose-dependent hepatotoxic potential...
- Herbal and dietary supplement hepatotoxicityVictor J Navarro
Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
Semin Liver Dis 29:373-82. 2009....
- Use of over-the-counter analgesics in patients with chronic liver disease: physicians' recommendationsSimona Rossi
Thomas Jefferson University Hospital and Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
Drug Saf 31:261-70. 2008..Therefore, the primary aim of this study was to assess healthcare providers' recommendations on how OTCAs should be used by patients with CLD...
- Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network databaseS Simona Jakab
Department of Medicine, Division of Gastroenterology and Hepatology, Jefferson Medical College, Thomas Jefferson University, and Department of Tissue Typing, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
Liver Transpl 13:1405-13. 2007..unrelated pairs. In conclusion, our results show no detrimental impact of close HLA matching on graft survival in adult LDLT, including in recipients with underlying autoimmune liver disease...
- Antiviral therapy of HCV in the cirrhotic and transplant candidateSteven K Herrine
Division of Gastroenterology and Hepatology, Thomas Jefferson University, 132 S 10th Street, Suite 450, Philadelphia, PA 19107, USA
Int J Med Sci 3:75-8. 2006..This approach needs to be pursued with caution given the potential morbidity of the therapy. Recently, a low accelerating dosage regimen has provided excellent results and is the subject of additional inquiry...
- Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective StudyElizabeth X Zheng
Einstein Medical Center, 5401 Old York Road, Philadelphia, PA, 19141, USA
Drug Saf 39:749-54. 2016..We aimed to describe the course and outcome of six patients who developed liver injury attributed to SLIMQUICK(®) weight loss products...
- Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicityStacey B Trooskin
Division of Gastroenterology and Hepatology, Thomas Jefferson University, Suite 480 Main Building, Philadelphia, PA 19107, USA
World J Gastroenterol 13:1074-8. 2007..To determine rates of hepatitis C (HCV) risk factor ascertainment, testing, and referral in urban primary care practices, with particular attention to the effect of race and ethnicity...
- Compensated hepatitis C: unenhanced MR imaging correlated with pathologic grading and stagingDonald G Mitchell
Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA
Abdom Imaging 33:58-64. 2008..We prospectively examined unenhanced MR imaging findings in relation to pathologic fibrosis, inflammation and steatosis in patients with compensated chronic hepatitis C viral infection (HCV)...
- Chronic liver disease in the primary care practices of Waterbury, ConnecticutVictor J Navarro
Hepatology 38:1062. 2003
- Quantifying the burden of chronic viral hepatitis-related cirrhosis hospitalizations in New Haven County, ConnecticutAmanda J Durante
Yale Center for Public Health, New Haven, CT 06510, USA
Conn Med 72:393-7. 2008..Given the long period between initial infection and clinical decompensation, screening and treatment programs aimed at reducing viral hepatitis-related morbidity should reduce hospitalization rates...